Online Mindfulness-Based Cognitive Therapy in Depressed Sample
iMBCT
Evaluating the Effectiveness of an Online 6-weeks Mindfulness-Based Cognitive Therapy in Depressed Sample: a Randomized Three-arm Clinical Trial
1 other identifier
interventional
170
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of the online 6-weeks Mindfulness-Based Cognitive Therapy (iMBCT) in depressed sample and compare the guided intervention to an unguided one. The main questions the study aims to answer are:
- To what extent completing iMBCT will reduce the severity of depressive symptoms in mild to moderately depressed sample?
- What are the differences in participants who completed the program or responded to treatment and those who discontinued it?
- What are the differences in treatment effect between two active conditions (guided and unguided iMBCT) and a passive one - waiting-list group? Researchers will compare two iMBCT interventions with a waiting-list group to assess the therapeutic effects of iMBCT on depression, anxiety and other measures related to the mental health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2023
CompletedFirst Posted
Study publicly available on registry
June 26, 2023
CompletedStudy Start
First participant enrolled
March 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 29, 2024
CompletedNovember 25, 2024
June 1, 2023
5 months
May 31, 2023
November 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in levels of depression - first tool
The Patient Health Questionnaire (PHQ-9): It is a brief self-administered tool for screening and assessing depression severity according to the DSM criteria (Kroenke et al., 2001). Respondents rate the statements on a 4-points scale, yielding a score between 0 and 27.
Baseline, week 6 and week 18
Change in levels of depression - second tool
To increase the reliability of diagnosis, second tool measuring depression will be used: The Center for Epidemiologic Studies Depression Scale (Radloff, 1977). It is a 20-item instrument with each item rated on a four-point scale ranging from 0 ("rarely or none of the time") to 3 ("most or all of the time").
Baseline, week 6 and week 18
Change in levels of anxiety
Generalized Anxiety Disorder (GAD-7) scale: it is a brief tool that consists of seven items measuring worry and anxiety symptoms. (Spitzer et al., 2006). Each item is scored on a four-point Likert scale (0-3) with total scores ranging from 0 to 21 with higher scores reflecting greater anxiety severity.
Baseline, week 6 and week 18
Change in levels of self-compassion
Self-compassion will be measured with a short form of Self-Compassion Scale (SCS-SF; Raes et al., 2011). The tool consists of 12 items (eg. 'I try to see my failings as part of the human condition.') to which person refers on a five-point scale.
Baseline, week 6 and week 18
Change in level of resilience
The level of resilience will be computed with polish Resilience Measurement Scale (The Resiliency Assessment Scale, SPP-25; Ogińska - Bulik, Juczyński, 2008). The scale consists of 25 statements (e. g. I can easily adapt to new situations) to which respondent relates on a five-point Likert scale.
Baseline, week 6 and week 18
Change in levels of mindfulness
Five Facet Mindfulness Questionnaire-15 (FFMQ-15): It is a short tool to measure mindfulness as a trait. The items will be measured on a 5-point Likert-type scale from 1 (never or rarely true) to 5 (very often or always true). Example items include: "I do jobs or tasks automatically without being aware of what I'm doing"
Baseline, week 6 and week 18
Secondary Outcomes (3)
Change in levels of rumination
Baseline, week 6 and week 18
Change in levels of cognitive fusion
Baseline, week 6 and week 18
Change in levels of experiential avoidance
Baseline, week 6 and week 18
Other Outcomes (6)
Ecological momentary assessment
Week 1,2 and 6
Working Alliance
week 2
Credibility and Expectancy
week 2
- +3 more other outcomes
Study Arms (3)
Unguided iMBCT intervention
EXPERIMENTALGuided iMBCT intervention
EXPERIMENTALWaiting list group
NO INTERVENTIONInterventions
The unguided iMBCT intervention is divided into six sessions. The sessions are an online adaptation of the regular MBCT. Subsequent sessions are unlocked gradually, once a week. The training consists of audio/video recordings and a workbook. Materials are recorded by a certified MBCT teacher and represent topics raised during regular courses: 1. Awareness and automatic pilot 2. Living in our heads 3. Being present in the body 4. Recognizing aversion 5. Allowing / Letting be 6. "How can I best take care of myself?" The intervention requires daily commitment of about 30-40 minutes.
The guided iMBCT intervention consists of six online meetings in groups of maximum 25 participants. The weekly meetings will be led by an experienced and certified MBCT teacher. The course of the meeting will represent thematically the unguided condition according to the agenda: * Introduction to the topic * Guided meditation * Brief inquiry and discussion * Setting tasks for the upcoming week To reduce the number of differences between the conditions as much as possible and narrow it down to the active participation of the teacher, the meetings will be modified version of MBCT and will last maximum 90 minutes. Between the meetings participants will be ask to practice daily 30-40 minutes mindfulness exercises.
Eligibility Criteria
You may qualify if:
- meeting the screening criterions for depression
- confirmed diagnosis in the clinical interview - mild to moderate depressive episode
- years old or older
- informed consent
- fluent in Polish
- willing to be randomized to intervention or waiting list group
You may not qualify if:
- lack of depressive symptoms constituting mild or moderate episode of depression
- suicidality
- severe depression
- current substance use disorder, psychotic disorders, bipolar
- current psychotherapy
- if antidepressant medication: has not been stable over the last 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Warsaw
Warsaw, Poland
Related Publications (5)
Surewicz WK. Effect of osmotic gradient on the physical properties of membrane lipids in liposomes. Chem Phys Lipids. 1983 Jul;33(1):81-5. doi: 10.1016/0009-3084(83)90010-5.
PMID: 6313244BACKGROUNDTeasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000 Aug;68(4):615-23. doi: 10.1037//0022-006x.68.4.615.
PMID: 10965637BACKGROUNDGoldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, Simpson TL. Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2018 Feb;59:52-60. doi: 10.1016/j.cpr.2017.10.011. Epub 2017 Nov 8.
PMID: 29126747BACKGROUNDSegal ZV, Dimidjian S, Beck A, Boggs JM, Vanderkruik R, Metcalf CA, Gallop R, Felder JN, Levy J. Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2020 Jun 1;77(6):563-573. doi: 10.1001/jamapsychiatry.2019.4693.
PMID: 31995132BACKGROUNDChariyalertsak S, Sugano K, Ohkura H, Mori Y. Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer. Tumour Biol. 1994;15(5):294-303. doi: 10.1159/000217904.
PMID: 7991990BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Wardęszkiewicz, MSc
University of Warsaw
- STUDY CHAIR
Paweł Holas, Ph.D.
University of Warsaw
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Msc
Study Record Dates
First Submitted
May 31, 2023
First Posted
June 26, 2023
Study Start
March 18, 2024
Primary Completion
July 31, 2024
Study Completion
October 29, 2024
Last Updated
November 25, 2024
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share
We will provide data upon reasonable request.